InnoCan Pharma Corporation (CSE:INNO)
Canada
· Delayed Price · Currency is CAD 6.24
+0.24 (4.00%)
Apr 28, 2026, 12:06 PM EST
InnoCan Pharma Revenue
In the year 2025, InnoCan Pharma had annual revenue of $26.61M USD, down -9.60%. InnoCan Pharma had revenue of $4.99M in the quarter ending December 31, 2025, a decrease of -7.65%.
Revenue
$26.61M
Revenue Growth
-9.60%
P/S Ratio
0.77
Revenue / Employee
n/a
Employees
n/a
Market Cap
28.07M CAD
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Loblaw Companies | 63.90B |
| Dollarama | 7.26B |
| George Weston | 64.51B |
| Metro | 22.18B |
| Eastwood Bio-Medical Canada | 719.58K |
| Swiss Water Decaffeinated Coffee | 258.72M |
| Nepra Foods | 6.05M |
| Burcon NutraScience | 1.48M |
InnoCan Pharma News
- 4 weeks ago - Innocan Pharma Reports 2025 Financial Results, with Revenues at US $26.6M - PRNewsWire
- 2 months ago - FDA Center for Veterinary Medicine Grants Innocan a Fee Waiver in 2026 for the Third Consecutive Time - PRNewsWire
- 2 months ago - Innocan Pharma Announces LPT-CBD demonstrates Pain Relief over Placebo-Results from a randomized blinded clinical study in Dogs - PRNewsWire
- 3 months ago - Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering - PRNewsWire
- 5 months ago - InnoCan Pharma Earnings Call Transcript: Q3 2025 - Transcripts
- 2 years ago - Innocan Pharma Announces Brokered LIFE Offering of Units for Up to $3 Million - GlobeNewsWire
- 3 years ago - Innocan Pharma Announces Launch of CBD Veterinary Commercialization Team - Newsfile Corp
- 3 years ago - Innocan Pharma Announces First Patent Grant in the United States - Newsfile Corp